You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 252 No. 10, September 14, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Indications for Pacing in the Treatment of Bradyarrhythmias

Report of an Independent Study Group

Brendan Phibbs, MD; Howard S. Friedman, MD; Thomas B. Graboys, MD; Bernard Lown, MD; Henry J. L. Marriott, MD; William P. Nelson, MD; Thomas Preston, MD

JAMA. 1984;252(10):1307-1311.


Abstract

Indications for permanent pacing in the bradyarrhythmias are summarized. In the absence of symptoms, pacing is justified only when Mobitz type II block or complete atrioventricular (AV) block is localized in the bundlebranch system. All other abnormalities of impulse generation or conduction (incomplete AV block of any type, atrial fibrillation with slow ventricular response, or sinus node dysfunction) must be shown to be stable and intrinsic and to cause CNS symptoms or hemodynamic compromise to justify pacing. Isolated intra-Hisian abnormality without failure of AV conduction is benign. Measurement of HV interval does not contribute significant information. Correlation of carotid sinus sensitivity with carotid sinus syncope is poor (5%). Bradyarrhythmia produced by minimal effective doses of an essential drug is a rare indication for pacing and requires special documentation. Inadequate indications, sources of error, and misconceptions are discussed. Generally, it is important to exclude drug effect, transient clinical states, and correctable systemic disease as causes of the abnormality before making a conclusion about pacing.

(JAMA 1984;252:1307-1311)



Author Affiliations

From the Heart Station, Kino Community Hospital, and the Section of Cardiology, University of Arizona Medical Center, Tucson (Dr Phibbs); the Department of Cardiology, Brooklyn Hospital, and the State University of New York Downstate Medical Center, Brooklyn (Dr Friedman); the Section of Cardiology (Dr Graboys) and the School of Public Health (Dr Lown), Harvard University Medical School, Boston; the Rogers Heart Foundation, St Petersburg, Fla (Dr Marriott); the Section of Cardiology, University of South Florida Medical Center, Tampa (Dr Nelson); and the Section of Cardiology, University of Washington Medical Center, Seattle (Dr Preston).


Footnotes

Reprint requests to Kino Community Hospital, 2800 E Ajo Way, Tucson, AZ 85713 (Dr Phibbs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progress in Cardiac Pacing: Part I
Shively and Goldschlager
Arch Intern Med 1985;145:2103-2106.
ABSTRACT  

High-Grade Atrioventricular Blocks
Phipps
JAMA 1985;254:57-57.
ABSTRACT  

Indications for Cardiac Pacing in Patients With Bradyarrhythmias: Do We Know All the Answers?
Bhandari and Rahimtoola
JAMA 1984;252:1327-1328.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.